Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway.
Saved in:
| Title: | Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. |
|---|---|
| Authors: | Shain AH; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA., Garrido M; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA., Botton T; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA., Talevich E; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA., Yeh I; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA., Sanborn JZ; Five3 Genomics, LLC, Santa Cruz, California, USA., Chung J; Samsung Advanced Institute of Technology, Seoul, Korea., Wang NJ; Department of Biomedical Engineering, Oregon Health and Sciences University, Portland, Oregon, USA.; Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, USA., Kakavand H; Melanoma Institute Australia, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia., Mann GJ; Melanoma Institute Australia, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia., Thompson JF; Melanoma Institute Australia, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Wiesner T; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Roy R; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA., Olshen AB; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Gagnon A; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA., Gray JW; Department of Biomedical Engineering, Oregon Health and Sciences University, Portland, Oregon, USA.; Knight Cancer Institute, Oregon Health and Sciences University, Portland, Oregon, USA., Huh N; Samsung Advanced Institute of Technology, Seoul, Korea., Hur JS; Samsung Electronics Headquarters, Seoul, Korea., Busam KJ; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Scolyer RA; Melanoma Institute Australia, Sydney, New South Wales, Australia.; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Cho RJ; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA., Murali R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Bastian BC; Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA.; Department of Dermatology, University of California, San Francisco, San Francisco, California, USA. |
| Source: | Nature genetics [Nat Genet] 2015 Oct; Vol. 47 (10), pp. 1194-9. Date of Electronic Publication: 2015 Sep 07. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
